retatrutide triple agonist glp-1 gip glucagon phase 2 obesity Targeting GLP-1, & GCG in and Type Diabetes Research Retatrutide is a next-generation triple-pathway
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

























